Literature DB >> 24392332

Apoptosis in the iris and trabecular meshwork of medically treated and untreated primary open angle glaucoma patients.

Zeynep Aktas1, Emine Esra Karaca1, Ipek Işik Gonul2, Murat Hasanreisoglu1, Merih Onol3.   

Abstract

AIM: To compare the trabecular meshwork (TM) and iris apoptosis of treated and untreated primary open angle glaucoma (POAG) patients.
METHODS: Eight treatment-naive, newly diagnosed (group 1) and 11 medicaly treated (group 2) patients with POAG were included in the study. Each patient underwent a limbus-based trabeculectomy. The TM and peripheral iris specimens were dissected out and were snap-frozen in liquid nitrogen and stored at -80°C until they were assayed. Apoptosis in each group was assesed by TUNEL method.
RESULTS: The mean patient age was 60.6±5.8 years (53-68 years) vs 58.9±8.9 years (47-70 years) in group 1 and group 2 (P=0.859). The mean treatment time in group 2 was 22.2±7.3 months (12-34 months). Apoptotic indexes in TM and iris were significantly higher in POAG patients using medication (group 2) compared to treatment-naive POAG patients (group 1) (P=0.004, 0.015; respectively).
CONCLUSION: Long term administration of topical antiglaucoma medications causes additional toxic effects on TM.

Entities:  

Keywords:  apoptosis; glaucoma; trabecular meshwork

Year:  2013        PMID: 24392332      PMCID: PMC3874523          DOI: 10.3980/j.issn.2222-3959.2013.06.15

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  25 in total

1.  Rapid and delayed death of cultured trabecular meshwork cells after selective laser trabeculoplasty.

Authors:  John P M Wood; Malcolm Plunkett; Victor Previn; Glyn Chidlow; Robert J Casson
Journal:  Lasers Surg Med       Date:  2010-04       Impact factor: 4.025

2.  Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals.

Authors:  J Alvarado; C Murphy; R Juster
Journal:  Ophthalmology       Date:  1984-06       Impact factor: 12.079

3.  Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells.

Authors:  Kwou-Yeung Wu; Hwei-Zu Wang; Show-Jen Hong
Journal:  Kaohsiung J Med Sci       Date:  2007-03       Impact factor: 2.744

4.  The effects of combination glaucoma medications on ocular surface epithelial cells.

Authors:  David A Ammar; Malik Y Kahook
Journal:  Adv Ther       Date:  2009-11-18       Impact factor: 3.845

5.  Corneal and conjunctival changes caused by commonly used glaucoma medications.

Authors:  Robert J Noecker; Lisa A Herrygers; Raana Anwaruddin
Journal:  Cornea       Date:  2004-07       Impact factor: 2.651

6.  In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells.

Authors:  Pascale Hamard; Catherine Blondin; Caroline Debbasch; Jean-Michel Warnet; Christophe Baudouin; Françoise Brignole
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-07       Impact factor: 3.117

7.  The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways.

Authors:  Christophe Baudouin; Hong Liang; Pascale Hamard; Luisa Riancho; Catherine Creuzot-Garcher; Jean-Michel Warnet; Françoise Brignole-Baudouin
Journal:  Ophthalmology       Date:  2007-05-29       Impact factor: 12.079

8.  The role of Schlemm's canal in aqueous outflow from the human eye.

Authors:  M C Johnson; R D Kamm
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-03       Impact factor: 4.799

Review 9.  Apoptosis and necrosis: detection, discrimination and phagocytosis.

Authors:  Dmitri V Krysko; Tom Vanden Berghe; Katharina D'Herde; Peter Vandenabeele
Journal:  Methods       Date:  2008-03       Impact factor: 3.608

10.  Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.

Authors:  H Liang; C Baudouin; A Pauly; F Brignole-Baudouin
Journal:  Br J Ophthalmol       Date:  2008-09       Impact factor: 4.638

View more
  5 in total

1.  Switch to Autophagy the Key Mechanism for Trabecular Meshwork Death in Severe Glaucoma.

Authors:  Aparna Rao; Prity Sahay; Munmun Chakraborty; Birendra Kumar Prusty; Sandhya Srinivasan; Gagan Deep Jhingan; Pragyan Mishra; Rahul Modak; Mrutyunjay Suar
Journal:  Clin Ophthalmol       Date:  2021-07-14

2.  Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA).

Authors:  Vanessa M Beutgen; Natarajan Perumal; Norbert Pfeiffer; Franz H Grus
Journal:  Front Immunol       Date:  2019-03-07       Impact factor: 7.561

3.  Integrative transcriptomic and proteomic analysis reveals CD9/ITGA4/PI3K-Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma.

Authors:  Junwei Yan; Xuejiao Yang; Xuefei Jiao; Xian Yang; Mingjin Guo; Yunqing Chen; Lu Zhan; Wenshi Chen
Journal:  J Cell Mol Med       Date:  2019-11-03       Impact factor: 5.310

4.  TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.

Authors:  Esther L Ashworth Briggs; Tze'Yo Toh; Rajaraman Eri; Alex W Hewitt; Anthony L Cook
Journal:  Mol Vis       Date:  2015-10-13       Impact factor: 2.367

Review 5.  Mechanisms of secondary degeneration after partial optic nerve transection.

Authors:  Hong-Ying Li; Yi-Wen Ruan; Chao-Ran Ren; Qi Cui; Kwok-Fai So
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.